Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Burt, Richard K
[Clear All Filters]
2020
Burt RK
,
Tappenden P
,
Han X
,
Quigley K
,
Arnautovic I
,
Sharrack B
,
Snowden JA
,
Hartung D
.
Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America.
Mult Scler Relat Disord. 2020;45:102404.
PubMed
Google Scholar
2019
Burt RK
,
Balabanov R
,
Burman J
,
Sharrack B
,
Snowden JA
,
Oliveira MCarolina
,
Fagius J
,
Rose J
,
Nelson F
,
Barreira AAntunes
, et al.
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
JAMA. 2019;321(2):165-174.
PubMed
Google Scholar
2016
Burt RK
,
Ruiz MA
,
Kaiser RL
.
Stem Cell Transplantation for Refractory Crohn Disease.
JAMA. 2016;315(23):2620.
PubMed
Google Scholar
2015
Burt RK
,
Balabanov R
,
Han X
,
Sharrack B
,
Morgan A
,
Quigley K
,
Yaung K
,
Helenowski IB
,
Jovanovic B
,
Spahovic D
, et al.
Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis.
JAMA. 2015;313(3):275-284.
PubMed
Google Scholar
2014
Burt RK
,
Oliveira MCarolina
,
Shah SJ
.
Cardiac Assessment Before Stem Cell Transplantation for Systemic Sclerosis.
JAMA. 2014;312(17):1803.
PubMed
Google Scholar
2013
Abrahamsson SV
,
Angelini DF
,
Dubinsky AN
,
Morel E
,
Oh U
,
Jones JL
,
Carassiti D
,
Reynolds R
,
Salvetti M
,
Calabresi PA
, et al.
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.
Brain. 2013.
PubMed
Google Scholar